Our events calendar
A complete list of events we're attending, or holding. From conferences and exhibitions, to open evenings and department visits - meet our team and see our technology in action.
Coronavirus (COVID-19) Statement
Fluidic Analytics continues to monitor the COVID-19 pandemic closely in the interest of our employees', their families and our industry community. Any decision to cancel our attendance at future events will be made based on the guidance of the World Health Organization (WHO), the European Commission, and the regulations/restrictions put in place by local/regional authorities. Many meetings will take place virtually; we continue to work with our event partners to support their meeting objectives and minimise disruption for attendees.
Bitesize Webinar Series
Revisit our informative webinar series on a new approach to in-solution immunoassays. All less than 15 minutes long - perfect for your coffee break. Watch the latest webinar here.
All antibodies are NOT created equal: Comprehensive profiling of SARS-CoV-2 antibodies
25 September 2020
Detecting antibodies that confer effective immunity is crucially important to understand a patient’s immune response to SARS-CoV-2. In particular, the ability to quantify the virus-neutralizing capacity of the immune system is key to support the development of suitable vaccines and antibody-based treatments such as convalescent plasma therapies.
This talk outlines our efforts in assessing the immune response in COVID-19 patients by use of a novel microfluidic in-solution immunoassay platform. With this new approach, we were able to comprehensively profile SARS-CoV-2 antibodies directly in minimally diluted serum of these patients.
RSC Chemical Biology and Bio-organic Group Postgraduate Symposium
11 September 2020
This RSC Chemical Biology and Bio-organic Group Postgraduate Symposium is dedicated to providing platform for PhD students from a broad range of chemical biology backgrounds to come together, share their work and discuss the latest research.
Case studies, presentations, panel debates & roundtable discussions focused on the key issues in protein & antibody engineering, bispecifics discovery, biotherapeutics development and bioanalysis, as well as the latest insights into production & manufacturing.
The R&D Series features 3 outstanding programmes bringing together Europe’s most successful pharmaceutical organisations, top biotech companies and internationally renowned academic institutions specialising in therapeutic areas.
COVID-19: Comprehensive Profiling of SARS-CoV-2 Antibodies - All antibodies are not created equal
Postponed from July 2020, the FEBS Congress provides a platform for international scientific exchange and showcases the newest developments in biochemistry, molecular biology and related areas.
Find Fluidic Analytics in the exhibition area with the Fluidity One-W, and ask us about our newest application studies.
Bioprocess professionals from across the world will share practical experience to help the bioprocess community solve today’s challenges, leading to tomorrow’s advances.
Peptide-membrane interactions: Faraday Discussion
Burlington House, London
8 - 10 September 2021
This meeting is aimed at established scientists, post-graduate students and industrial researchers interested in the fundamental questions of cell biology including how peptides and proteins behave within biological membranes. Given the importance of improving our understanding of how macromolecules such as peptides interact with membranes, the unique format of the Faraday Discussions will allow for in-depth discussions and opportunities to establish new collaborations.
Find Stephanie in the exhibition foyer with the Fluidity One-W, and ask us about our newest application studies.
Postponed from October 2020. The official congress theme ‘Clinical Proteomics for the Benefit of the Patients’ brings together biopharma and biotech drug developments, for the first time involving Pharma Industry in one of the foremost arenas for the advancement of life sciences – a natural next step considering that knowledge derived from proteomics research is playing an increasingly important role in drug development.